Trending Now
We have updated our Privacy Policy and Terms of Use for Eurasia Group and its affiliates, including GZERO Media, to clarify the types of data we collect, how we collect it, how we use data and with whom we share data. By using our website you consent to our Terms and Conditions and Privacy Policy, including the transfer of your personal data to the United States from your country of residence, and our use of cookies described in our Cookie Policy.
{{ subpage.title }}
How AI is transforming medicine, and the cancer fight
In 1971, President Nixon declared a “War on Cancer.” Fifty years and billions in research later, the disease still kills 1,700 Americans a day—and survival often depends on income, race, and access to care. But could artificial intelligence finally give humanity the upper hand?
On the latest episode of GZERO World, Ian Bremmer sits down with cancer researcher and bestselling author Siddhartha Mukherjee to explore how AI is changing the trajectory of modern medicine. From early detection and diagnostics to drug discovery and personalized treatment, Mukherjee believes we're entering a new era in the fight against cancer.
“The machine learns it, and it learns it forever,” Mukherjee says, describing how AI can now generate new chemical compounds that have never existed—potentially designing cancer drugs from scratch. “You don’t need to train a new generation of chemists. The machine will now learn it for eternity.”
Mukherjee explains how this generative power can unlock faster, cheaper breakthroughs across all stages of cancer treatment—from identifying new carcinogens like “forever chemicals” to tailoring therapies to a patient’s specific biology. For a disease that touches almost every family, these advances aren’t just technological—they’re deeply personal.
GZERO World with Ian Bremmer, the award-winning weekly global affairs series, airs nationwide on US public television stations (check local listings).
New digital episodes of GZERO World are released every Monday on YouTube.Don't miss an episode: subscribe to GZERO's YouTube channel and turn on notifications (🔔). GZERO World with Ian Bremmer airs on US public television weekly - check local listings.
Could the future of industry lie among the stars?
Listen: Creating artificial human retinas in zero gravity. Mining rare minerals on the moon. There seems to be no limit to what could be possible if we continue to take our more important industries to space. Join Mike Massimino and Mike Greenley on this episode of Next Giant Leap as they explore the industrialization of space. Dr. Joan Saary sheds light on the potential of designing medical treatments in microgravity and treating astronauts in orbit, and Dr. Gordon Osinski explains the exciting future of resource extraction on other planetary objects.
Next Giant Leap, hosted by MDA Space CEO Mike Greenley and former NASA astronaut Mike Massimino, is a podcast series that explores how business and innovation are transforming space—and life on Earth. From national security to military technology to medical discoveries, the two Mikes talk to leading experts about the risks, opportunities, and big questions of the new Space Age.
Graphic Truth: National Institutes for Health funding in peril
The Trump administration wants to slash the budget of the National Institutes of Health (NIH), the US’ main medical research institution, by 40% for the next fiscal year.
The move would bring funding levels back to those of the early 1990s, before a huge post-Cold War push to increase non-military R&D nearly doubled the NIH budget.
The current, Trump-appointed NIH Director Dr. Jay Bhattacharya reaffirmed his agency’s commitment to addressing “the health needs of all Americans” before the senate on Tuesday. At the same time, more than 300 current and recently terminated NIH employees have accused the director of suspending federal grant funding for ideological reasons.
Here’s a look at how Trump’s proposed cuts stack up against NIH funding over the past 30 years.
Coronavirus' effect on health may linger; expert warns of more patients with both flu and Covid-19
BEIJING (CHINA DAILY/ASIA NEWS NETWORK) - Covid-19 and related diseases may cause lasting health problems, with more than 70 per cent of patients who have recovered still showing at least one symptom after they are well, according to a study.
Indian scientists develop new paper-strip test for Covid 19
A fast and easy paper-strip test for Covid 19, much like a pregnancy test, is set to hit the market, and it could be a game changer for India as it seeks to curb the coronavirus pandemic.
Takeda-led Covid-19 plasma treatment enters clinical trial with first patient
TOKYO (REUTERS) - Japan's Takeda Pharmaceutical Co said on Friday (Oct 9) an alliance of drugmakers it spearheads has enrolled its first patient in a global clinical trial of a blood plasma treatment for Covid-19 after months of regulatory delays.
Coronavirus: One in three South Korean Covid-19 patients improve with remdesivir drug
SEOUL (REUTERS) - One in three South Korean patients seriously ill with Covid-19 showed an improvement in their condition after being given Gilead Sciences's antiviral remdesivir, health authorities said.
Global trial of anti-malarial drug backed by Trump stalls
Recruitment of subjects for a major global trial to determine whether an anti-malarial drug can ward off the coronavirus has stalled, after the World Health Organisation (WHO) suspended its own clinical trials on treating Covid-19 patients.